Loading...

Amarin CEO on Future of Heart Drug Vascepa

6,130 views

Loading...

Loading...

Transcript

The interactive transcript could not be loaded.

Loading...

Rating is available when the video has been rented.
This feature is not available right now. Please try again later.
Published on Nov 20, 2018

Nov.20 -- John Thero, chief executive officer at Amarin, talks about early results for their heart drug Vascepa. David Kotok, chairman and chief investment officer at Cumberland Advisors, joins the conversation on "Bloomberg Daybreak: Americas."

Loading...

When autoplay is enabled, a suggested video will automatically play next.

Up next


to add this to Watch Later

Add to

Loading playlists...